By David Williams2012-07-02T17:34:00
The drugs industry expects the NHS to cut its real terms spend on new medicines over the next three years - but it is warning that the slow adoption of new drugs could create avoidable costs.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud